Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
- 31 August 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (9), 541-549
- https://doi.org/10.1056/nejm199508313330902
Abstract
Sulfonylurea drugs have been the only oral therapy available for patients with non-insulin-dependent diabetes mellitus (NIDDM) in the United States. Recently, however, metformin has been approved for the treatment of NIDDM.This publication has 24 references indexed in Scilit:
- Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDMDiabetes, 1995
- Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose productionDiabetes, 1994
- Nutrition Recommendations and Principles for People With Diabetes MellitusDiabetes Care, 1994
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Combined metformin-sulfonylurea treatment of patients with noninsulin- dependent diabetes in fair to poor glycemic controlJournal of Clinical Endocrinology & Metabolism, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetesActa Endocrinologica, 1989
- Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yrDiabetes, 1987
- Effect of Metformin on Insulin-Stimulated Glucose Turnover and Insulin Binding to Receptors in Type II DiabetesDiabetes Care, 1987
- Retinopathy in older type II diabetics. Association with glucose controlDiabetes, 1986